beetroot® digital health solutions

About Us

beetroot® digital health solutions is a platform comprising a number of modules that enable monitoring of patients safely and at scale. We improve patient safety by automating the monitoring of test results, investigations and wellbeing data for people living with chronic disease and/or cancer.


Do you need to monitor patients on medications or living with chronic disease or cancer?

Do you need to identify these things?

  • abnormal results
  • deteriorating trends
  • Did Not Attends for testing
  • early recurrence of disease
  • decline in health or wellbeing

Yes?

Then you need beetroot® digital monitoring



Problem: monitoring patients living with autoimmune disease or cancer is time consuming and risk-prone - patients can get 'lost' so that deteriorations and recurrence of disease isn't spotted quickly enough to avoid unnecessary interventions

Solution: use beetroot digital technology to help check enrolled patients' health and wellbeing stability and identify issues as early as possible.

beetroot modules are used by over 35 NHS and public sector customers in England, providing these benefits:

PATIENTS: Reassurance & Convenience

  • Reminders to go for testing; education and information; getting tested where it’s convenient; submitting wellbeing information when it’s convenient.

ORGANISATION: Workforce & Reduced Risk

  • Releasing key clinical staff from mundane manual tasks to concentrate on real care; reducing risk by automating monitoring and identification of non-compliance.

ECONOMIC: Controlled Care

  • Streamlining the use of expensive medication, helping to avoid non-elective interventions by improving proactive management of patients.


QE Gateshead Rheumatology has been proud to work with THERAPYAUDIT for over 2 decades with a hybrid model for monitoring of blood tests for immunosuppressive drugs in rheumatology. It is a clinically and cost effective way of working with patients having their blood tests done in their GP practice whilst getting consultants’ opinion on any abnormal blood tests. This DMARD monitoring platform has evolved into a clinical system for diagnostic data, customer care system for managing helpline queries, patient & clinician reported outcomes, and a rich source of audit & research. We couldn’t have managed all the urgent communications with patients during the Covid pandemic without this clinical system.“

Dr Vadivelu Saravanan, Consultant Rheumatologist, Queen Elizabeth Hospital, Gateshead, UK


find more at www.beetroothealth.com


Useful Information

beetrootDMARD Summary

View document

beetrootCANCER Summary

View document

Find us at an Event

Arab Health 2023
Dubai, UAE
Hall 2, Stand No: H50. 15
30 Jan - 2 Feb 2023

ADDRESS

Century Hourse, Market Square, Swavesey
Cambridge
CB24 4QG
United Kingdom

WEBSITE

Visit website

SOCIAL

Let’s connect